CytomX Therapeutics CTMX
NASDAQ CTMX
$2.56 -0.07 (-2.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Cash & Current Investments (2014 - 2026)

Updated

CytomX Therapeutics' Cash & Current Investments was $330.28 million in Q2 2026, up 108.9% from $158.09 million a year earlier but down 4.7% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at CytomX Therapeutics came in at $137.05 million, up 36.2% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $100.62 million in FY2024 (-42.3%), $174.51 million in FY2023 (-9.9%), $193.65 million in FY2022 (-36.6%) and $305.23 million in FY2021 (-3.4%).
  • Quarterly Cash & Current Investments has moved between $79.89 million (Q1 2025) and $346.71 million (Q1 2026) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for five straight quarters, with growth averaging 48.5% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2026 (growth of 334.0%); the worst was Q1 2025 (a decline of 46.8%).
  • Per Business Quant data, CTMX's Cash & Current Investments in the three quarters before Q2 2026 was $346.71 million (Q1 2026), $137.05 million (Q4 2025) and $143.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 CytomX Therapeutics 557.82 Mn -399.84 Mn - 330.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 330.28 Mn
Mar 31, 2026 346.71 Mn
Dec 31, 2025 137.05 Mn
Sep 30, 2025 143.63 Mn
Jun 30, 2025 158.09 Mn
Mar 31, 2025 79.89 Mn
Dec 31, 2024 100.62 Mn
Sep 30, 2024 117.59 Mn
Jun 30, 2024 137.18 Mn
Mar 31, 2024 150.28 Mn
Dec 31, 2023 174.51 Mn
Sep 30, 2023 194.11 Mn
Jun 30, 2023 180.86 Mn
Mar 31, 2023 204.50 Mn
Dec 31, 2022 193.65 Mn
Sep 30, 2022 194.29 Mn
Jun 30, 2022 228.17 Mn
Mar 31, 2022 262.53 Mn
Dec 31, 2021 305.23 Mn
Sep 30, 2021 236.29 Mn
API Access

CytomX Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CTMX&period=max&api_key=YOUR_API_KEY